Intel stock dips before the bell after report ties Nvidia, Apple to future chip work
29 January 2026
1 min read

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work

New York, January 29, 2026, 08:59 (EST) — Premarket

  • Intel shares dipped in premarket action after yesterday’s strong rally
  • Intel is reportedly discussing limited production runs for 2028 with Nvidia and Apple, a new report reveals
  • A recent filing showed CFO David Zinsner bought Intel shares earlier this week

Intel Corp (INTC.O) shares fell 1.5% to $48.04 in premarket trading Thursday, after jumping 11% to $48.78 the day before. 1

Volatility in the stock is again linked to a well-known challenge: can Intel turn its factories into a real business instead of just promises? Investors are looking for solid proof that Intel’s foundry unit—the contract chipmaking division—can secure and keep big clients.

A report late Wednesday reignited speculation that Nvidia and Apple might lean on Intel for some limited production in 2028. DigiTimes said both companies are still keeping Taiwan Semiconductor Manufacturing Co. as their main supplier. The piece highlighted Nvidia’s upcoming “Feynman” GPUs and a lower-cost Apple Mac chip as part of the discussions. 2

A regulatory filing showed Intel CFO David Zinsner bought 5,882 shares on Jan. 26, paying $42.50 each for a total near $250,000. 3

Intel jumped Wednesday, boosted by a broader chip stock rally after South Korea’s SK Hynix posted record quarterly profits and Dutch chip-equipment leader ASML revealed its largest-ever fourth-quarter order backlog, according to Reuters. The Federal Reserve held rates steady. “Whether you were bullish or bearish going into the press conference you walked away feeling about the same,” said Michael James, an equity sales trader at Rosenblatt Securities. 4

Intel forecasted first-quarter revenue in the range of $11.7 billion to $12.7 billion last week, aiming for an adjusted break-even. This comes after a fourth quarter where revenue hit $13.7 billion and adjusted earnings were 15 cents per share. “We expect our available supply to be at its lowest level in Q1 before improving in Q2 and beyond,” CFO David Zinsner said in the earnings release. CEO Lip-Bu Tan noted the company is “working aggressively to grow supply to meet strong customer demand” for its 18A manufacturing technology products. 5

The report zeroes in on 2028, not the next quarter, spotlighting supply-chain challenges. Any shift depends on Intel hitting tough manufacturing yield and cost targets, with chip buyers ready to switch gears quickly if deadlines slip.

Earnings and rate forecasts have driven the wider market, with chip stocks swinging sharply on each AI spending and factory capacity update.

Apple’s earnings report, set for release after Thursday’s close, is under the spotlight for insights into demand trends and supply-chain spending. Investors will also be watching closely for any hints that confirm or debunk the Nvidia/Apple chatter that shook Intel’s stock earlier this week. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Eightco (ORBS) stock pops in premarket — what’s driving the move after-hours
Previous Story

Eightco (ORBS) stock pops in premarket — what’s driving the move after-hours

Nvidia stock jumps in premarket as CEO flags China H200 decision — what NVDA traders watch next
Next Story

Nvidia stock jumps in premarket as CEO flags China H200 decision — what NVDA traders watch next

Go toTop